1) Battersby S, Ogilvie AD, Blackwood DHR, et al:Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3' untranslated region of the human serotonin transporter gene. J Neurochem 72:1384-1388, 1999
2) Cloninger CR, Svrakic DM:Integrative psychobiological approach to psychiatric assessment and treatment. Psychiatry 60:120-141, 1997
3) 池田匡志,阿部徳一郎,他:話題になった遺伝子多型のその後―セロトニントランスポーター(5-HTT)遺伝子多型.分子精神医学 3:60-68, 2003
4) Kent L, Doerry U, Hardy E, et al:Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder(ADHD):Analysis and pooled analysis. Mol Psychiatry 7:908-912, 2002
5) Kim SJ, Kim YS, Choi NK, et al:Serotonin transporter gene polymorphism and personality traits in a Korean population. Neuropsychobiology 51:243-247, 2005
6) Kim SJ, Kim YS, Lee HS, et al:An interaction between the serotonin transporter promoter region and dopamine transporter polymorphisms contributes to harm avoidance and reward dependence traits in normal healthy subjects. J Neural Transm 113:877-886, 2006
7) 木島伸彦,斎藤令衣,竹内美香,他:Cloningerの気質と性格の7次元モデルおよび日本語版Temperament and Character Inventory(TCI).精神科診断 7:379-399, 1996
8) Kumakiri C, Kodama K, Shimizu E, et al:Study of the association between the serotonin transporter gene regulatory region polymorphism and personality traits in a Japanese population. Neurosci Lett 263:205-207, 1999
9) Mongini F, Fassino S, Rota E, et al:The temperament and character inventory in women with migraine. J Headache Pain 6:247-249, 2005
10) 中村雅之,佐野輝:精神科領域の用語解説;セロトニントランスポーター.分子精神医学 5:72-74, 2005
11) Samochowiec J, Rybakowski F, Czerski P, et al:Polymorphisms in the dopamine, serotonin and norepinephrine transporter genes and their relationship to temperamental dimensions measured by the temperament and character inventory in healthy volunteers. Neuropsychobiology 43:248-253, 2001
12) Samochowiec J, Syrek S, Michal P, et al:Polymorphisms in the serotonin transporter and monoamine oxidase A genes and their relationship to personality traits measured by the temperament and character inventory and NEO Five-Factor Inventory in healthy volunteers. Neuropsychobiology 50:174-181, 2004
13) 仙波恵美子:痛みとセロトニン―受容体サブタイプについての最近の知見.医のあゆみ 195:605-608, 2000
14) Szekely A, Ronai Z, Nemoda Z, et al:Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms. Am J Med Genet B Neuropsychiatr Genet 126B:106-110, 2004
15) 竹内美香,吉野相英,大野裕,他:Cloningerの3次元人格(TDP)理論および日本語版Tridimensional Personality Questionnaire(TPQ).精神科診断 3:491-505, 1992
16) Yamaguchi S, Suzuki Y, Tanaka S, et al:Mental state and sensory thresholds. Kitasato Med J 34:64-69, 2004
17) 吉村恵,古江秀昌,伊藤彰敏:薬理作用と生理作用 鎮痛メカニズム―下行性セロトニン痛覚抑制系の関与.日本臨牀 63:211-213, 2005